You are currently viewing a new version of our website. To view the old version click .

Iron Metabolism, Redox Balance and Neurological Diseases

This special issue belongs to the section “Health Outcomes of Antioxidants and Oxidative Stress“.

Special Issue Information

Dear Colleagues,

The misregulation of brain iron homeostasis can lead to severe pathological changes in the neurological system. Iron deficiency slows the development of the neural system and causes mental and emotional disorders, while iron overload is closely related to neurodegenerative diseases such as Alzheimer’s disease, Parkinson’s disease and cerebral ischemia. Free iron can elicit the generation of reactive oxygen species (ROS) due to its ability to catalyze the Fenton reaction, which contributes significantly to the pathophysiological mechanisms of neurological diseases. On the other hand, some free radicals also play an important role in the normal function of cells as signaling molecules. Iron misregulation and redox imbalance are the keys to the occurrence and development of many neurological diseases. Therefore, iron metabolism and redox regulation as targets have become or will become a great potential solution for the treatment of neurological diseases. This Special Issue aims to collect the latest research findings and review articles with great advances on the mechanisms or treatments of neurological diseases related to iron misregulation/redox imbalance, and to stimulate new thinking in the field of iron metabolism, redox balance and neurological diseases.

Prof. Dr. Yan-Zhong Chang
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Antioxidants is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • iron metabolism
  • redox
  • Alzheimer's disease
  • Parkinson's disease
  • stroke
  • antioxidants
  • brain-targeted nanomedicines

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.

Published Papers

Get Alerted

Add your email address to receive forthcoming issues of this journal.

XFacebookLinkedIn
Antioxidants - ISSN 2076-3921